Cargando…
Drug-induced liver injury: Towards early prediction and risk stratification
Drug-induced liver injury (DILI) is a hot topic for clinicians, academia, drug companies and regulators, as shown by the steadily increasing number of publications and agents listed as causing liver damage (http://livertox.nih.gov/). As it was the case in the past decade with drug-induced QT prolong...
Autores principales: | Raschi, Emanuel, De Ponti, Fabrizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220269/ https://www.ncbi.nlm.nih.gov/pubmed/28105256 http://dx.doi.org/10.4254/wjh.v9.i1.30 |
Ejemplares similares
-
Strategies for Early Prediction and Timely Recognition of Drug-Induced Liver Injury: The Case of Cyclin-Dependent Kinase 4/6 Inhibitors
por: Raschi, Emanuel, et al.
Publicado: (2019) -
Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis
por: Gatti, Milo, et al.
Publicado: (2020) -
Role of immune dysfunction in drug induced liver injury
por: Girish, Chandrashekaran, et al.
Publicado: (2021) -
Liver Injury with Nintedanib: A Pharmacovigilance–Pharmacokinetic Appraisal
por: Raschi, Emanuel, et al.
Publicado: (2022) -
Noninvasive scores for the prediction of esophageal varices and risk stratification in patients with cirrhosis
por: Bangaru, Saroja, et al.
Publicado: (2020)